The authors argue for a return to in vivo experimentation in cardiovascular physiology to better understand the relative contributions of molecular mechanisms discovered in vitro.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
W. Gil Wier (2014) conducted an editorial in Cardiovascular physiology and hypertension. In vivo experimentation (optical biosensor mice and two-photon microscopy) vs. Ex vivo experimentation was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: